An online survey of hypothyroid patients demonstrates prominent dissatisfaction

Sarah J. Peterson, Anne R. Cappola, M. Regina Castro, Colin M. Dayan, Alan P. Farwell, James V. Hennessey, Peter A. Kopp, Douglas S. Ross, Mary H. Samuels, Anna M. Sawka, Peter N. Taylor, Jacqueline Jonklaas, Antonio C. Bianco

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Approximately 15% more patients taking levothyroxine (LT4) report impaired quality of life compared to controls. This could be explained by additional diagnoses independently affecting quality of life and complicating assignment of causation. This study sought to investigate the underpinnings of reduced quality of life in hypothyroid patients and to provide data for discussion at a symposium addressing hypothyroidism. Methods: An online survey for hypothyroid patients was posted on the American Thyroid Association Web site and forwarded to multiple groups. Respondents were asked to rank satisfaction with their treatment for hypothyroidism and their treating physician. They also ranked their perception regarding physician knowledge about hypothyroidism treatments, need for new treatments, and life impact of hypothyroidism on a scale of 1-10. Respondents reported the therapy they were taking, categorized as LT4, LT4 and liothyronine (LT4 + LT3), or desiccated thyroid extract (DTE). They also reported sex, age, cause of hypothyroidism, duration of treatment, additional diagnoses, and prevalence of symptoms. Results: A total of 12,146 individuals completed the survey. The overall degree of satisfaction was 5 (interquartile range [IQR] = 3-8). Among respondents without self-reported depression, stressors, or medical conditions (n = 3670), individuals taking DTE reported a higher median treatment satisfaction of 7 (IQR = 5-9) compared to other treatments. At the same time, the LT4 treatment group exhibited the lowest satisfaction of 5 (IQR = 3-7), and for the LT4 + LT3 treatment group, satisfaction was 6 (IQR = 3-8). Respondents taking DTE were also less likely to report problems with weight management, fatigue/energy levels, mood, and memory compared to those taking LT4 or LT4 + LT3. Conclusions: A subset of patients with hypothyroidism are not satisfied with their current therapy or their physicians. Higher satisfaction with both treatment and physicians is reported by those patients on DTE. While the study design does not provide a mechanistic explanation for this observation, future studies should investigate whether preference for DTE is related to triiodothyronine levels or other unidentified causes.

Original languageEnglish (US)
Pages (from-to)707-721
Number of pages15
JournalThyroid
Volume28
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Thyroid (USP)
Hypothyroidism
Therapeutics
Physicians
Quality of Life
Triiodothyronine
Surveys and Questionnaires
Thyroxine
Causality
Fatigue
Depression
Weights and Measures

Keywords

  • combination therapy
  • desiccated thyroid extract
  • hypothyroidism
  • levothyroxine
  • T3
  • TSH

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hennessey, J. V., ... Bianco, A. C. (2018). An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid, 28(6), 707-721. https://doi.org/10.1089/thy.2017.0681

An online survey of hypothyroid patients demonstrates prominent dissatisfaction. / Peterson, Sarah J.; Cappola, Anne R.; Castro, M. Regina; Dayan, Colin M.; Farwell, Alan P.; Hennessey, James V.; Kopp, Peter A.; Ross, Douglas S.; Samuels, Mary H.; Sawka, Anna M.; Taylor, Peter N.; Jonklaas, Jacqueline; Bianco, Antonio C.

In: Thyroid, Vol. 28, No. 6, 01.06.2018, p. 707-721.

Research output: Contribution to journalArticle

Peterson, SJ, Cappola, AR, Castro, MR, Dayan, CM, Farwell, AP, Hennessey, JV, Kopp, PA, Ross, DS, Samuels, MH, Sawka, AM, Taylor, PN, Jonklaas, J & Bianco, AC 2018, 'An online survey of hypothyroid patients demonstrates prominent dissatisfaction', Thyroid, vol. 28, no. 6, pp. 707-721. https://doi.org/10.1089/thy.2017.0681
Peterson SJ, Cappola AR, Castro MR, Dayan CM, Farwell AP, Hennessey JV et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid. 2018 Jun 1;28(6):707-721. https://doi.org/10.1089/thy.2017.0681
Peterson, Sarah J. ; Cappola, Anne R. ; Castro, M. Regina ; Dayan, Colin M. ; Farwell, Alan P. ; Hennessey, James V. ; Kopp, Peter A. ; Ross, Douglas S. ; Samuels, Mary H. ; Sawka, Anna M. ; Taylor, Peter N. ; Jonklaas, Jacqueline ; Bianco, Antonio C. / An online survey of hypothyroid patients demonstrates prominent dissatisfaction. In: Thyroid. 2018 ; Vol. 28, No. 6. pp. 707-721.
@article{2c04a9871b584438884b3996958ce63f,
title = "An online survey of hypothyroid patients demonstrates prominent dissatisfaction",
abstract = "Background: Approximately 15{\%} more patients taking levothyroxine (LT4) report impaired quality of life compared to controls. This could be explained by additional diagnoses independently affecting quality of life and complicating assignment of causation. This study sought to investigate the underpinnings of reduced quality of life in hypothyroid patients and to provide data for discussion at a symposium addressing hypothyroidism. Methods: An online survey for hypothyroid patients was posted on the American Thyroid Association Web site and forwarded to multiple groups. Respondents were asked to rank satisfaction with their treatment for hypothyroidism and their treating physician. They also ranked their perception regarding physician knowledge about hypothyroidism treatments, need for new treatments, and life impact of hypothyroidism on a scale of 1-10. Respondents reported the therapy they were taking, categorized as LT4, LT4 and liothyronine (LT4 + LT3), or desiccated thyroid extract (DTE). They also reported sex, age, cause of hypothyroidism, duration of treatment, additional diagnoses, and prevalence of symptoms. Results: A total of 12,146 individuals completed the survey. The overall degree of satisfaction was 5 (interquartile range [IQR] = 3-8). Among respondents without self-reported depression, stressors, or medical conditions (n = 3670), individuals taking DTE reported a higher median treatment satisfaction of 7 (IQR = 5-9) compared to other treatments. At the same time, the LT4 treatment group exhibited the lowest satisfaction of 5 (IQR = 3-7), and for the LT4 + LT3 treatment group, satisfaction was 6 (IQR = 3-8). Respondents taking DTE were also less likely to report problems with weight management, fatigue/energy levels, mood, and memory compared to those taking LT4 or LT4 + LT3. Conclusions: A subset of patients with hypothyroidism are not satisfied with their current therapy or their physicians. Higher satisfaction with both treatment and physicians is reported by those patients on DTE. While the study design does not provide a mechanistic explanation for this observation, future studies should investigate whether preference for DTE is related to triiodothyronine levels or other unidentified causes.",
keywords = "combination therapy, desiccated thyroid extract, hypothyroidism, levothyroxine, T3, TSH",
author = "Peterson, {Sarah J.} and Cappola, {Anne R.} and Castro, {M. Regina} and Dayan, {Colin M.} and Farwell, {Alan P.} and Hennessey, {James V.} and Kopp, {Peter A.} and Ross, {Douglas S.} and Samuels, {Mary H.} and Sawka, {Anna M.} and Taylor, {Peter N.} and Jacqueline Jonklaas and Bianco, {Antonio C.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1089/thy.2017.0681",
language = "English (US)",
volume = "28",
pages = "707--721",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - An online survey of hypothyroid patients demonstrates prominent dissatisfaction

AU - Peterson, Sarah J.

AU - Cappola, Anne R.

AU - Castro, M. Regina

AU - Dayan, Colin M.

AU - Farwell, Alan P.

AU - Hennessey, James V.

AU - Kopp, Peter A.

AU - Ross, Douglas S.

AU - Samuels, Mary H.

AU - Sawka, Anna M.

AU - Taylor, Peter N.

AU - Jonklaas, Jacqueline

AU - Bianco, Antonio C.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background: Approximately 15% more patients taking levothyroxine (LT4) report impaired quality of life compared to controls. This could be explained by additional diagnoses independently affecting quality of life and complicating assignment of causation. This study sought to investigate the underpinnings of reduced quality of life in hypothyroid patients and to provide data for discussion at a symposium addressing hypothyroidism. Methods: An online survey for hypothyroid patients was posted on the American Thyroid Association Web site and forwarded to multiple groups. Respondents were asked to rank satisfaction with their treatment for hypothyroidism and their treating physician. They also ranked their perception regarding physician knowledge about hypothyroidism treatments, need for new treatments, and life impact of hypothyroidism on a scale of 1-10. Respondents reported the therapy they were taking, categorized as LT4, LT4 and liothyronine (LT4 + LT3), or desiccated thyroid extract (DTE). They also reported sex, age, cause of hypothyroidism, duration of treatment, additional diagnoses, and prevalence of symptoms. Results: A total of 12,146 individuals completed the survey. The overall degree of satisfaction was 5 (interquartile range [IQR] = 3-8). Among respondents without self-reported depression, stressors, or medical conditions (n = 3670), individuals taking DTE reported a higher median treatment satisfaction of 7 (IQR = 5-9) compared to other treatments. At the same time, the LT4 treatment group exhibited the lowest satisfaction of 5 (IQR = 3-7), and for the LT4 + LT3 treatment group, satisfaction was 6 (IQR = 3-8). Respondents taking DTE were also less likely to report problems with weight management, fatigue/energy levels, mood, and memory compared to those taking LT4 or LT4 + LT3. Conclusions: A subset of patients with hypothyroidism are not satisfied with their current therapy or their physicians. Higher satisfaction with both treatment and physicians is reported by those patients on DTE. While the study design does not provide a mechanistic explanation for this observation, future studies should investigate whether preference for DTE is related to triiodothyronine levels or other unidentified causes.

AB - Background: Approximately 15% more patients taking levothyroxine (LT4) report impaired quality of life compared to controls. This could be explained by additional diagnoses independently affecting quality of life and complicating assignment of causation. This study sought to investigate the underpinnings of reduced quality of life in hypothyroid patients and to provide data for discussion at a symposium addressing hypothyroidism. Methods: An online survey for hypothyroid patients was posted on the American Thyroid Association Web site and forwarded to multiple groups. Respondents were asked to rank satisfaction with their treatment for hypothyroidism and their treating physician. They also ranked their perception regarding physician knowledge about hypothyroidism treatments, need for new treatments, and life impact of hypothyroidism on a scale of 1-10. Respondents reported the therapy they were taking, categorized as LT4, LT4 and liothyronine (LT4 + LT3), or desiccated thyroid extract (DTE). They also reported sex, age, cause of hypothyroidism, duration of treatment, additional diagnoses, and prevalence of symptoms. Results: A total of 12,146 individuals completed the survey. The overall degree of satisfaction was 5 (interquartile range [IQR] = 3-8). Among respondents without self-reported depression, stressors, or medical conditions (n = 3670), individuals taking DTE reported a higher median treatment satisfaction of 7 (IQR = 5-9) compared to other treatments. At the same time, the LT4 treatment group exhibited the lowest satisfaction of 5 (IQR = 3-7), and for the LT4 + LT3 treatment group, satisfaction was 6 (IQR = 3-8). Respondents taking DTE were also less likely to report problems with weight management, fatigue/energy levels, mood, and memory compared to those taking LT4 or LT4 + LT3. Conclusions: A subset of patients with hypothyroidism are not satisfied with their current therapy or their physicians. Higher satisfaction with both treatment and physicians is reported by those patients on DTE. While the study design does not provide a mechanistic explanation for this observation, future studies should investigate whether preference for DTE is related to triiodothyronine levels or other unidentified causes.

KW - combination therapy

KW - desiccated thyroid extract

KW - hypothyroidism

KW - levothyroxine

KW - T3

KW - TSH

UR - http://www.scopus.com/inward/record.url?scp=85048443938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048443938&partnerID=8YFLogxK

U2 - 10.1089/thy.2017.0681

DO - 10.1089/thy.2017.0681

M3 - Article

VL - 28

SP - 707

EP - 721

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 6

ER -